Cancer

INDICATION: Lymphoma; renal cancer

Cell culture and mouse studies suggest SIRPA inhibitors could help treat Burkitt's lymphoma and renal cell carcinoma (RCC). In a CD20-positive Burkitt's lymphoma cell line

Read the full 281 word article

User Sign In